2016 ESC Position Paper on Cancer Treatments and Cardiovascular Toxicity Developed Under the Auspices of the ESC Committee for Practice Guidelines: The Task Force for Cancer Treatments and Cardiovascular Toxicity of the European Society of Cardiology (ESC)

Eur Heart J. 2016 Sep 21;37(36):2768-2801. doi: 10.1093/eurheartj/ehw211. Epub 2016 Aug 26.

Abstract

No abstract available

Keywords: European Society of Cardiology; arrhythmias; cancer therapy; cardio-oncology; cardiotoxicity; chemotherapy; early detection; ischaemia; myocardial dysfunction; surveillance.

Publication types

  • Practice Guideline

MeSH terms

  • Advisory Committees
  • Antineoplastic Agents / adverse effects
  • Cancer Survivors
  • Cardiology*
  • Cardiotoxicity / diagnosis
  • Cardiotoxicity / etiology*
  • Cardiotoxicity / therapy*
  • Humans
  • Immunotherapy / adverse effects
  • Neoplasms / therapy*
  • Radiotherapy / adverse effects
  • Societies, Medical*
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors

Substances

  • Antineoplastic Agents
  • Vascular Endothelial Growth Factor A